MAPT and Alzheimer disease: In addition, activation of the tau kinases, GSK-3 and cdk5 were also found to occur in Braak stage II-III tissues, and these preceded global elevations in tau phosphorylation and the loss of post-synaptic markers observed in late-stage AD.